EN | UA
EN | UA

Help Support

Back

Efficacy of Tegoprazan vs Lansoprazole-based quadruple therapy for H. pylori infection

Tegoprazan-based bismuth quadruple therapy Tegoprazan-based bismuth quadruple therapy
Tegoprazan-based bismuth quadruple therapy Tegoprazan-based bismuth quadruple therapy

The effectiveness and safety of Tegoprazan-based bismuth quadruple therapy (TBMT) and Lansoprazole-based bismuth quadruple therapy (LBMT) were compared in eradicating Helicobacter pylori (H. pylori).

See All

Key take away

Tegoprazan-based bismuth quadruple therapy shows a non-inferior eradication rate and comparable adverse events to Lansoprazole-based bismuth quadruple therapy when used as the primary regimen for H. pylori management.

Background

The effectiveness and safety of Tegoprazan-based bismuth quadruple therapy (TBMT) and Lansoprazole-based bismuth quadruple therapy (LBMT) were compared in eradicating Helicobacter pylori (H. pylori).

Method

The study included adults aged 18 and above who had an H. pylori infection and no prior history of H. pylori elimination. Either Giemsa staining or rapid urease test was utilized to diagnose H. pylori illness. A total of 217 participants were randomized to receive either TBMT (n = 108) or LBMT (n = 109).

Result

In this randomized, double-blind, active-controlled study, TBMT demonstrated greater rates of elimination than LBMT. Table 1 illustrates the elimination rates of TBMT and LBMT in the per-protocol (PP), corresponding modified ITT, and intention-to-treat (ITT) analyses.

The occurrence of adverse events did not significantly differ between TBMT and LBMT groups (39.1% vs. 43.4%).

Conclusion

TBMT exhibited a non-inferior elimination rate and comparable occurrence of adverse events to LBMT as a first-line elimination regimen. The findings suggest that the substitution of proton pump inhibitors with Tegoprazan in bismuth quadruple therapy could lead to better elimination rates.

Source:

Helicobacter

Article:

Efficacy of tegoprazan-based bismuth quadruple therapy compared with bismuth quadruple therapy for Helicobacter pylori infection: A randomized, double-blind, active-controlled study

Authors:

Joon Sung Kim et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru ua
Try: